Moreover, CD24 was reported to express in various other malignant conditions, including B-cell lymphomas, gliomas, lung, breast, urothelial tumors and pancreatic cancer [23,24] and a second primary affecting the CD24 result cannot be excluded. This evidence concerns the gene CD24 and B-cell non-Hodgkin lymphoma.